期刊文献+

甲状腺微小乳头状癌治疗策略的共识与争议 被引量:3

Consensus and controversy on treatment strategies for papillary thyroid microcarcinoma
原文传递
导出
摘要 近年来,甲状腺微小乳头状癌(papillary thyroid microcarcinoma,PTMC)患病率急剧上升。PTMC的规范治疗越来越受到临床医生的关注。目前,PTMC的主要治疗策略包括手术治疗、积极监测、热消融治疗等。手术治疗是甲状腺癌的标准治疗,但PTMC手术的必要性和手术范围尚存在争议。而积极监测和热消融治疗都是基于循证医学证据的新治疗策略,尤其对低危PTMC取得了良好的治疗效果。本文就PTMC的3种治疗策略及国内外共识与争议进行综述,以期提供良好的治疗引导。 In recent years,the prevalence of papillary thyroid microcarcinoma(PTMC) has risen sharply.The standard treatment of PTMC has attracted more and more attention of clinicians.At present,the main treatment strategies for PTMC include surgical treatment,active surveillance,thermal ablation,etc.Surgical treatment is the standard treatment for thyroid cancer,but the necessity and scope of PTMC surgery are still controversial.Active surveillance and thermal ablation therapy are new treatment strategies based on evidence-based medicine,and have achieved good therapeutic effects especially on low-risk PTMC.This article reviews the three treatment strategies of PTMC and their domestic and international consensus and controversies,in order to provide good treatment guidance.
作者 梁凯 胡慧青 崔晨 侯新国 陈丽 Liang Kai;Hu Huiqing;Cui Chen;Hou Xinguo;Chen Li(Department of Endocrinology and Metabolic Diseases,Qilu Hospital of Shandong University,Institute of Endocrine and Metabolic Diseases of Shandong University,Key Laboratory of Endocrine and Metabolic Diseases,Shandong Province Medicine&Health,Jinan Clinical Research Center for Endocrine and Metabolic Diseases,Jinan 250012,China)
出处 《国际内分泌代谢杂志》 2023年第2期100-103,112,共5页 International Journal of Endocrinology and Metabolism
关键词 甲状腺微小乳头状癌 手术治疗 积极监测 热消融治疗 Papillary thyroid microcarcinoma Surgical treatment Active surveillance Thermal ablation
  • 相关文献

参考文献4

二级参考文献78

  • 1范建霞,关海霞,吕朝晖,田文,武晓泓,无.妊娠期和产后分化型甲状腺癌促甲状腺激素抑制治疗中国专家共识(2019版)[J].中国实用外科杂志,2020,40(3):255-259. 被引量:12
  • 2American Thyroid Association (ATA) Guidelines Taskforce on Thy- roid Nodules and Differentiated Thyroid Cancer, Cooper DS, Doherty GM, et al. Revised American thyroid association manage- ment guidelines for patients with thyroid nodules and differentiat- ed thyroid cancer[J]. Thyroid, 2009, 19(11):1167-1214.
  • 3Haugen BR, Alexander EK, Bible KC, et al. 2015 American thyroid as- sociation management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American thyroid as- sociation guidelines task force on thyroid nodules and differentiat- ed thyroid cancer[J]. Thyroid, 2016, 26(1):1-133.
  • 4Tuttle RM, Haddad RI, Ball DW, et al. Thyroid carcinoma, version 2.2014[J]. J Natl Compr Canc Netw, 2014, 12(12):1671-1680.
  • 5Xing MZ. Molecular pathogenesis and mechanisms of thyroid can- cer[J]. Nat Rev Cancer, 2013, 13(3):184-199.
  • 6De Biase D, Gandolfi G, Ragazzi M, et al. TERT promoter mutations in papillary thyroid microcarcinomas[J]. Thyroid, 2015, 25(9):1013- 1019.
  • 7Ito Y, Miyauchi A, Inoue H, et al. An observational trial for papillary thyroid microcarcinoma in Japanese patients[J]. World J Surg, 2010, 34(1):28-35.
  • 8Ito Y, Uruno T, Nakano K, et al. An observation trial without surgical treatment in patients with papillary microcarcinoma of the thyroid [J]. Thyroid, 2003, 13(4):381-387.
  • 9Xing M, Alzahrani AS, Carson KA, et al. Association between BRAF V600E mutation and recurrence of papillary thyroid cancer[J]. J Clin Oncol, 2015, 33(1):42-50.
  • 10Jiang LH, Chen C, Tan Z, et al. Clinical characteristics related to central lymph node metastasis in cN0 papillary thyroid carcinoma: a retro- spective study of 916 patients[J]. Int J Endocrinol, 2014, 2014:385787.

共引文献600

同被引文献22

引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部